共 110 条
[1]
Ballatore C(2007)Tau-mediated neurodegeneration in Alzheimer's disease and related disorders Nat. Rev. Neurosci. 8 663-672
[2]
Lee VM(2012)Tau-targeted treatment strategies in Alzheimer's disease Br. J. Pharmacol. 165 1246-1259
[3]
Trojanowski JQ(2011)Mapping the road forward in Alzheimer's disease Sci. Transl. Med. 3 114ps148-213
[4]
Götz J(2011)Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift Neuron 69 203-712
[5]
Ittner A(2011)The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nat. Rev. Drug Discov. 10 698-1506
[6]
Ittner LM(2012)ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models Science 335 1503-1065
[7]
Holtzman DM(2011)Resolving controversies on the path to Alzheimer's therapeutics Nat. Med. 17 1060-12
[8]
Goate A(2003)Aph-1, Pen-2, and Nicastrin with Presenilin generate an active γ-Secretase complex Neuron 38 9-281
[9]
Kelly J(2010)The genetics of Alzheimer disease: back to the future Neuron 68 270-227
[10]
Sperling R(2010)Genetics of Alzheimer disease J. Geriatr. Psychiatry Neurol. 23 213-131